Curative potential of allogeneic hematopoietic stem cell transplant in type 1 diabetes

被引：4
|
作者：
McCabe, Kristen E. [1 ]
Pollock, Allison J. [1 ]
Rehm, Jennifer L. [1 ]
DeSantes, Kenneth B. [1 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53792 USA
来源：
PEDIATRIC DIABETES | 2017年 / 18卷 / 08期
关键词：
aplastic anemia; autoimmune; transplant; type; 1; diabetes; BONE-MARROW-TRANSPLANTATION; REDUCED INTENSITY; MELLITUS; CHILDREN; DISEASES; THERAPY; IMPACT; RISK;
D O I：
10.1111/pedi.12430
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The mainstay of treatment for type 1 diabetes (T1D) is exogenous insulin. Here, we report a case in which exogenous insulin requirements were eliminated after an allogeneic hematopoietic stem cell transplant for aplastic anemia in a pediatric patient recently diagnosed with T1D, and explore the validity of this approach compared with current treatments.
引用
收藏
页码：832 / 834
页数：3
相关论文
共 50 条
  • [1] Consent and allogeneic hematopoietic stem-cell transplant
    Berquier, Maxime
    HEMATOLOGIE, 2018, 24 (01): : 97 - 100
  • [2] Outcome Predictors of Allogeneic Hematopoietic Stem Cell Transplant
    Yang, Wen-Chi
    Chen, Yih-Ting
    Chang, Wei-Wen
    Chang, Chih-Hsiang
    Fan, Pei-Chun
    Lee, Shen-Yang
    Kao, Kuo-Chin
    Tian, Ya-Chung
    Hung, Cheng-Chieh
    Fang, Ji-Tseng
    Yang, Chih-Wei
    Chen, Yung-Chang
    Wang, Po-Nan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 345 (01): : 33 - 38
  • [3] Autologus Hematopoietic Stem Cell Transplant in Type 1 Diabetes Mellitus in a Nonmyeloablative and Outpatient Setting
    Graciela Cantu-Rodriguez, Olga
    Lavalle-Gonzalez, Fernando
    Angel Herrera-Rojas, Miguel
    Gutierrez-Aguirre, Cesar H.
    Mancias-Guerra, Consuelo
    Carlos Jaime-Perez, Jose
    Gonzalez-Llano, Oscar
    Zapata-Garrido, Alfonso
    Zacarias Villarreal-Perez, Jesus
    Gomez-Almaguer, David
    BLOOD, 2014, 124 (21)
  • [4] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION HAS CURATIVE POTENTIAL FOR CHEMOREFRACTORY NON-HODGKIN LYMPHOMA
    Kato, K.
    Krijanovski, O.
    Khaled, Y.
    Peres, E.
    Reddy, P.
    Choi, S.
    Kitko, C.
    Yanik, G.
    Levine, J.
    Ferrara, J.
    Mineishi, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 63 - 64
  • [5] Allogeneic hematopoietic stem cell transplant improves outcomes in fucosidosis
    Gupta, Ashish
    Lund, Troy
    Eisengart, Nicole
    Miettunen, Kelly
    Eisengart, Julie
    Braunlin, Elizabeth
    Orchard, Paul
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S66 - S66
  • [6] Fertility in Our Allogeneic Hematopoietic Stem Cell Transplant Patients
    Topcuoglu, Pervin
    Ataca, Pinar
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Konuk, Nahide
    Akan, Hamdi
    Ilhan, Osman
    Beksac, Meral
    Gurman, Gunhan
    BLOOD, 2014, 124 (21)
  • [7] Cytomegalovirus Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Barlow, Ashley
    US PHARMACIST, 2021, 46 (04)
  • [8] Extended duration letermovir in allogeneic hematopoietic stem cell transplant
    Hinman, Breanna
    Cox, James
    Umoru, Godsfavour
    Kamble, Rammurti
    Musick, Will
    TRANSPLANT IMMUNOLOGY, 2023, 81
  • [9] Primary care for allogeneic hematopoietic stem cell transplant recipients
    Fulcher, Jill
    Hertz, Sherrie
    Bredeson, Christopher
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (06) : E225 - E226
  • [10] Cigarette Smoking and Allogeneic Hematopoietic Stem Cell Transplant Outcomes
    Tran, B. T.
    Chien, J. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
12345